Enterotoxigenic Escherichia coli virulence factors and vaccine approaches
- 1 October 2004
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 3 (5) , 585-595
- https://doi.org/10.1586/14760584.3.5.585
Abstract
Enterotoxigenic Escherichia coli (ETEC) is recognized as one of the major causes of infectious diarrhea in developing countries. Worldwide, the incidence of ETEC infections is estimated to result in 650 million cases of diarrhea and 380,000 deaths in children under 5 years of age. ETEC is also an important cause of travelers' diarrhea in people traveling to endemic regions of the world. Although ETEC is an uncommon cause of infections in the USA, there have been 14 reported outbreaks of ETEC in the USA and seven on cruise ships over the 20-year period between 1975 and 1995. ETEC strains are comprised of a large number of serotypes that produce a variety of colonization factors and enterotoxins. On infection, ETEC first establishes itself by adhering to the epithelium of the small intestine via one or more colonization factor antigens or coli surface proteins. Once established, ETEC expresses one or more enterotoxin(s), which results in the production of secretory diarrhea. While the need for an efficacious, easily administered vaccine is great, there are currently no licensed ETEC vaccines available for use in endemic countries or for US travelers.Keywords
This publication has 31 references indexed in Scilit:
- Development of Pathogenicity‐Driven Definitions of Outcomes for a Field Trial of a Killed Oral Vaccine against EnterotoxigenicEscherichia coliin Egypt: Application of an Evidence‐Based MethodThe Journal of Infectious Diseases, 2004
- A plant-based multicomponent vaccine protects mice from enteric diseasesNature Biotechnology, 2001
- Induction of Systemic Antifimbria and Antitoxin Antibody Responses in Egyptian Children and Adults by an Oral, Killed Enterotoxigenic Escherichia coli plus Cholera Toxin B Subunit VaccineInfection and Immunity, 2001
- DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC)Vaccine, 2000
- Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli -Cholera Toxin B Subunit Vaccine in Israeli Young AdultsInfection and Immunity, 2000
- Pilot Study of phoP/phoQ -Deleted Salmonella enterica Serovar Typhimurium Expressing Helicobacter pylori Urease in Adult VolunteersInfection and Immunity, 2000
- Lack of Prophylactic Efficacy of an Enteric‐Coated Bovine Hyperimmune Milk Product against EnterotoxigenicEscherichia coliChallenge Administered during a Standard MealThe Journal of Infectious Diseases, 1999
- Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNAVaccine, 1998
- Colonization factors of human enterotoxigenic Escherichia coli (ETEC)Trends in Microbiology, 1996
- Pathogenesis ofEscherichia coliDiarrheaNew England Journal of Medicine, 1971